Rodent models of diabetic cardiomyopathy

被引:214
作者
Bugger, Heiko [2 ]
Abel, E. Dale [1 ,2 ]
机构
[1] Univ Utah, Sch Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84132 USA
[2] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84132 USA
基金
美国国家卫生研究院;
关键词
HIGH-FAT DIET; CARDIAC CONTRACTILE DYSFUNCTION; MYOCARDIAL SUBSTRATE METABOLISM; ISOLATED VENTRICULAR MYOCYTES; DIASTOLIC DYSFUNCTION; INSULIN-RESISTANCE; LEPTIN RECEPTOR; PERFUSED HEARTS; RETICULUM CA2+-ATPASE; ENERGY-METABOLISM;
D O I
10.1242/dmm.001941
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Diabetic cardiomyopathy increases the risk of heart failure in individuals with diabetes, independently of co-existing coronary artery disease and hypertension. The underlying mechanisms for this cardiac complication are incompletely understood. Research on rodent models of type 1 and type 2 diabetes, and the use of genetic engineering techniques in mice, have greatly advanced our understanding of the molecular mechanisms responsible for human diabetic cardiomyopathy. The adaptation of experimental techniques for the investigation of cardiac physiology in mice now allows comprehensive characterization of these models. The focus of the present review will be to discuss selected. rodent models that have proven to be useful in studying the underlying mechanisms of human diabetic cardiomyopathy, and to provide an overview of the characteristics of these models for the growing number of investigators who seek to understand the pathology of diabetes-related heart disease.
引用
收藏
页码:454 / 466
页数:13
相关论文
共 169 条
  • [91] Liporegulation in diet-induced obesity - The antisteatotic role of hyperleptinemia
    Lee, Y
    Wang, MY
    Kakuma, T
    Wang, ZW
    Babcock, E
    McCorkle, K
    Higa, M
    Zhou, YT
    Unger, RH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (08) : 5629 - 5635
  • [92] Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch
    Li, SY
    Yang, X
    Ceylan-Isik, AF
    Du, M
    Sreejayan, N
    Ren, J
    [J]. DIABETOLOGIA, 2006, 49 (06) : 1434 - 1446
  • [93] Overexpression of metallothionein reduces diabetic cardiomyopathy
    Liang, QR
    Carlson, EC
    Donthi, RV
    Kralik, PM
    Shen, X
    Epstein, PN
    [J]. DIABETES, 2002, 51 (01) : 174 - 181
  • [94] CARDIAC SARCOPLASMIC-RETICULUM FUNCTION IN INSULIN-TREATED OR CARNITINE-TREATED DIABETIC RATS
    LOPASCHUK, GD
    TAHILIANI, AG
    VADLAMUDI, RVSV
    KATZ, S
    MCNEILL, JH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (06): : H969 - H976
  • [95] Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling
    Lu, Zhongju
    Jiang, Ya-Ping
    Xu, Xin-Hua
    Ballou, Lisa M.
    Cohen, Ira S.
    Lin, Richard Z.
    [J]. DIABETES, 2007, 56 (11) : 2780 - 2789
  • [96] Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats
    Luiken, JJFP
    Arumugam, Y
    Dyck, DJ
    Bell, RC
    Pelsers, MML
    Turcotte, LP
    Tandon, NN
    Glatz, JFC
    Bonen, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40567 - 40573
  • [97] Leptin in immunology
    Matarese, G
    Moschos, S
    Mantzoros, CS
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (06) : 3137 - 3142
  • [98] Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts
    Mazumder, PK
    O'Neill, BT
    Roberts, MW
    Buchanan, J
    Yun, UJ
    Cooksey, RC
    Boudina, S
    Abel, ED
    [J]. DIABETES, 2004, 53 (09) : 2366 - 2374
  • [99] Cardiac steatosis in diabetes mellitus -: A 1H-magnetic resonance spectroscopy study
    McGavock, Jonathan M.
    Lingvay, Ildiko
    Zib, Ivana
    Tillery, Tommy
    Salas, Naomi
    Unger, Roger
    Levine, Benjamin D.
    Raskin, Philip
    Victor, Ronald G.
    Szczepaniak, Lidia S.
    [J]. CIRCULATION, 2007, 116 (10) : 1170 - 1175
  • [100] Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
    McMullen, JR
    Shioi, T
    Zhang, L
    Tarnavski, O
    Sherwood, MC
    Kang, PM
    Izumo, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) : 12355 - 12360